We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » COMMISSIONER DIRECTION WON'T CHANGE CRITICAL PATH
COMMISSIONER DIRECTION WON'T CHANGE CRITICAL PATH
November 4, 2004
The future of the FDA’s Critical Path Initiative — which aims to expedite the drug development process and bring more products to market — does not depend on who becomes the FDA commissioner next year, according a top agency official.